Janux Therapeutics, Inc. · NASDAQ:JANX
Adage Capital Management, L.P.'s stake in Janux Therapeutics, Inc. fell to 4.27% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 12, 2025
Adage Capital Management, L.P.'s stake in Janux Therapeutics, Inc. fell to 4.27%, 2,525,000 shares, as a passive investor on Jun 30, 2025. Filed Aug 12, 2025 (Schedule 13G/A).
- Stake
- 4.27%
- Shares
- 2,525,000
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adage Capital Management, L.P. | 4.27% | 2,525,000 |
| Robert Atchinson | 4.27% | 2,525,000 |
| Phillip Gross | 4.27% | 2,525,000 |
Source
Related
- Janux Therapeutics, Inc.
- Adage Capital Management, L.P.
- Janux Therapeutics, Inc. shareholders
- Schedule 13G · Adage Capital Management, L.P. · Feb 12, 2025
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Form 4 · Campbell David Alan · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Campbell David Alan · Jul 10, 2026